Nutritional and Metabolic Diseases

All Conditions

Symptoms and General Pathology

Neoplasms

Digestive System Diseases

Wasting Syndrome

Cachexia

Gastrointestinal Neoplasms

Digestive System Neoplasms

Syndrome

Weight Loss

Body Weight

Body Weight Changes

Thinness

Metabolic Diseases

Nutrition Disorders

Gastrointestinal Diseases

Central Nervous System Depressants

All Drugs and Chemicals

Anesthetics

Patients with cancer of digestive system requiring resection surgery will be included. They will have measure of height and weight, blood samples, skeletal muscle force, skeletal muscle index and muscle biopsy.

V1: Inclusion will be effectuated at the time of anaesthetic consultation V2: The day before and day of resection surgery about 1 month after V3: Follow-up at 1 month V4: Follow-up at 3 months V6: Follow-up at 6 months

Height and weight will be measured to estimate cachexia degree at the time of anaesthetic consultation. (V1)

Height and weight

Blood samples will be collected for measuring myostatin on blood at the time of anaesthetic consultation, the day before resection surgery, follow-ups at 1, 3 and 6 months. (V1, V2, V3, V4, V6)

Blood samples

Skeletal muscle force will be determined from Computerized Tomography (CT)-scan at the time of anaesthetic, follow-ups at 1, 3 and 6 months. (V1, V3, V4, V6)

Skeletal muscle force

Skeletal muscle index will be determined from Computerized Tomography (CT)-scan at the time of anaesthetic, follow-ups at 1, 3 and 6 months. (V1, V3, V4, V6)

Skeletal muscle index

Muscle biopsy will be performed during resection surgery under general anaesthesia. (V2)

Muscle biopsy

Karine ABBOUD, MD

Cancer cachexia is responsible for the death of approximately 20% of patients. Myostatin is a master negative regulator of skeletal muscle mass. If the role of myostatin in cancer cachexia is now well established in murine models, no study has focused on muscle expression of Myostatin in relation to the degree of cachexia. the hypothesize is that muscle Myostatin a biological marker of cachexia in patients with cancer of digestive system. The main objective is to compare skeletal muscle Myostatin messenger RiboNucleic Acid (mRNA) level as a function of cachexia in cancer of digestive system patients. Myostatin messenger RiboNucleic Acid (mRNA) level will be determined in a muscle sample taken during the resection under general anaesthesia. Skeletal muscle index will be determined before surgery, 3 and 6 months after surgery. Muscle strength of the lower and upper limbs will be determined before resection, at 1 month, 3 months and 6 months postoperatively. Blood sampling will also be performed on these 4 occasions.

Skeletal Muscle Expression of Myostatin and Cancer of Digestive System Associated Cachexia

Skeletal Muscle Expression of Myostatin and Cancer of Digestive System Associated Cachexia(MYOCAC Study)

Evaluate correlation between skeletal muscle force/index and degree myostatin. Skeletal muscle force/index will be determinated by skeletal muscle force/index results.

Degree myostatin will be determinated by blood samples with Enzyme Linked ImmunoSorbent Assay (ELISA) method.

Evaluate Correlation between skeletal muscle force and index before resection surgery to estimate the extent of cachexia-induced muscle dysfunction by results tests.

Evaluate correlation between level of myostatin muscular expression and degree myostatin.

Level of myostatin muscular expression will be determinated by muscle biopsy. Degree myostatin will be determinated by blood samples with Enzyme Linked ImmunoSorbent Assay (ELISA) method.

Determinate correlation between level of myostatin muscular expression and skeletal muscle force and index after resection surgery.

Analysis level of myostatin muscular expression and blood samples results according to cancer stage, neoadjuvant treatment and chemotherapy.

Centre Hospitalier Universitaire de Saint Etienne

Respiratory Tract (Lung and Bronchial) Diseases

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Subjects in exercise group will undergo individualized high aerobic interval training on treadmill for 30 minutes under the supervision of an experienced physical therapist 3 times a week and home exercise twice a week with accelerometer.

Subjects in control group will not undergo individualized high aerobic interval training on treadmill. They will receive usual care as normally does in hospital.

Exercise training

Usual care

Ying-Tai Wu, Ph.D

Cancer is one of the leading health issues in this country and worldwide. Angiogenesis is an essential process for tumoral growth and metastasis. This process is dependent on the balance between angiogenic factors and antiangiogenic factors. Muscle wasting has been associated with myostatin overexpression in cancer. Exercise training can depress tumor growth and suppress myostatin expression, and enhance skeletal muscle angiogenesis in healthy people and some animal studies. The purpose of this study is mainly to investigate the effects of exercise training on

1. circulating VEGF-A
2. muscle growth and function
3. Myostatin

Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients

Maximal oxygen consumption with Vmax229 Vastus lateral muscle oxygenation with NIRS

Analysis of circulating VEGF-A and myostatin

Isokinetic muscle strength and endurance with Biodex

Measured with 24-hour recall questionnaire

Body mass index calculated with body weight and height

% body fat abd free-fat mass with BIA

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Skeletal Muscle Expression of Myostatin and Cancer of Digestive System Associated Cachexia	NCT03172403	Cancer of Diges...	Height and weig... Blood samples Skeletal muscle... Skeletal muscle... Muscle biopsy	40 Years - 80 Years	Centre Hospitalier Universitaire de Saint Etienne
Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients	NCT01136083	Non-small-cell ...	Exercise traini... Usual care	40 Years - 75 Years	National Taiwan University Hospital
Skeletal Muscle Expression of Myostatin and Cancer of Digestive System Associated Cachexia	NCT03172403	Cancer of Diges...	Height and weig... Blood samples Skeletal muscle... Skeletal muscle... Muscle biopsy	40 Years - 80 Years	Centre Hospitalier Universitaire de Saint Etienne

Spots Global Cancer Trial Database for myostatin

Every month we try and update this database with for myostatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for myostatin

Every month we try and update this database with for myostatin cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for myostatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.